BLBD - Blue Bird Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Blue Bird Corp
The Company was incorporated in Delaware on September 24, 2013. On February 24, 2015 (the “Closing Date”), the Company consummated the previously announced business combination (the “Business Combination”), pursuant to which the Company acquired all of the outstanding capital stock of School Bus Holdings Inc. (“School Bus Holdings” or “SBH”) from The Traxis Group, B.V. (the “Seller”), in accordance with the purchase agreement, dated as of September 21, 2014, by and among the Company, the Seller and, solely for purposes of Section 10.01(a) thereof, Hennessy Capital Partners I LLC (the “HCAC Sponsor”), as amended on February 10, 2015 and February 18, 2015 (as so amended, the “Purchase Agreement”). Pursuant to the Purchase Agreement, the total purchase price was paid in a combination of cash in the amount of $100 million and in shares of the Company’s common stock, $0.0001 par value (the “Common Stock”) (12,000,000 shares valued at a total of $120 million).

In connection with the closing of the Business Combination, the Company changed its name from Hennessy Capital Acquisition Corp. to Blue Bird Corporation. Unless expressly stated otherwise in this Report, Blue Bird Corporation shall be referred to as “Blue Bird” or the “Company,” and includes its consolidated subsidiaries.

Losses Widen but Revenues Unchanged

In the first quarter Freedom Holding Corp increased losses of $-0.12 per share compare to $0.00 a year ago and eps fell from $0.03 per share from the previous quarter.

Sales remained unchanged to $7.40 millions from $0.00 millions in the same quarter a year ago and sequentially Sales Tumbled by -45.39 % from $13.56 millions.

American Bio Medica Corp announced second quarter operating shortfall of $-0.074 millions

In the second quarter American Bio Medica Corp reached break-even of $0.00 per share compare to $0.00 a year ago and from $-0.01 per share from the previous quarter.

Sales declined in double digits by -18.15 % to $1.07 millions from $1.31 millions in the same quarter a year ago and sequentially Sales increased by 2.69 % from $1.04 millions.

Break-even, Topline Crumbles

In the second quarter Skinvisible Inc reached break-even of $0.00 per share compare to $-0.01 a year ago and from $0.00 per share from the previous quarter.

Sales faded by -46.62 % to $0.02 millions from $0.04 millions in the same quarter a year ago and sequentially Sales surged by 42.55 % from $0.02 millions.

BLBD Company Profile

Losses Widen but Revenues Unchanged

American Bio Medica Corp announced second quarter operating shortfall of $-0.074 millions

Fusion Connect, Inc announced second quarter operating deficit of $-5.34 millions

Sales and Earnings Unchanged

Break-even, Topline Crumbles